Patent issued for mineral-based formula as pathogen mitigant

Oil-Dri receives U.S. patent for mineral-based technology for use in antibiotic-free animal protein production.

Oil-Dri Corporation of America, a leading manufacturer of sorbent minerals and parent company to Amlan International, announced that the U.S. Patent & Trademark Office has issued U.S. Patent 10,568,903, titled “Clay Product & Uses Thereof,” which covers two existing commercial products -- Varium for poultry and NeoPrime for swine -- that are helping global animal protein producers in an era of antibiotic-free production.

The patent provides a methodology for using a natural, mineral-based formula to mitigate the effects of exposure to pathogenic bacteria and the disease-causing toxins they produce, which damage gut health and function, the company said in its announcement. Advancements in natural feed additives are helping transform animal protein production by providing proven and reliable alternatives to in-feed antibiotics used to promote growth and productivity, Oil-Dri said.

“The U.S. is the second country to issue a patent for this mineral-based technology, and it validates the important role that minerals play in disrupting the cycle of intestinal disease,” Oil-Dri president and chief executive officer Daniel S. Jaffee said. “When using Varium, for example, poultry integrators have eliminated the use of in-feed antibiotics to promote growth while maintaining production efficiencies and profitability. Our customers report they are growing healthier birds that are less stressed and have increased the marketability of their products through improved skin, liver and feet quality.”

Amlan International president Flemming L. Mahs added, “The market opportunity for natural alternatives to antibiotics is large and growing. Market data indicate that within medicinal feed additives, anti-infectives are a $2.4 billion global market, and usage has been declining as a result of changing consumer sentiment towards the use of antibiotics and regulatory restrictions limiting the use of antibiotics in animal protein production. Intestinal disease costs the global livestock industry more than $6 billion annually in economic loss, and costs are rising as sub-therapeutic antibiotic use declines.”

Mineral-based technology

Unlike antibiotics, which are designed to kill bacteria, the patented technology includes a synergistic formula of three ingredients with distinct modes of action: (1) a surface-activated mineral that facilitates chemical binding of pathogenic intestinal bacteria and the disease-causing toxins they produce; (2) an immunomodulator that stimulates an animal’s innate immune system to naturally defend against disease, and (3) an energy source for the replenishment of intestinal epithelial cells that is essential for healthy gut function.

Oil-Dri Corporation of America, a Delaware corporation doing business as Amlan International, is a global leader in proven solutions that improve the intestinal health and productivity of livestock. Amlan has grown its product offering across the intestinal health and antibiotic growth promoter alternative market, driven largely by the research conducted at its laboratory campus in Vernon Hills, Ill.

Amlan International sells animal health products outside of the U.S.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish